神经钙黏蛋白(NCAD)重组蛋白

Recombinant N-cadherin (NCAD)

CDw325; CD325; CDHN; CDH2; Cadherin 2 Type 1; N-Cadherin

  • 神经钙黏蛋白(NCAD)重组蛋白 产品包装(模拟)
  • 神经钙黏蛋白(NCAD)重组蛋白 产品包装(模拟)
  • 神经钙黏蛋白(NCAD)重组蛋白 Figure . Gene Sequencing (extract)
  • RPB481Ra01.jpg SDS-PAGE图
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Rattus norvegicus (Rat,大鼠) 应用(仅供研究使用,不用于临床诊断!)
RPB481Ra02 神经钙黏蛋白(NCAD)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB481Ra03 神经钙黏蛋白(NCAD)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB481Ra01 神经钙黏蛋白(NCAD)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB481Ra02 神经钙黏蛋白(NCAD)多克隆抗体 WB; IHC; ICC; IP.
PAB481Ra03 神经钙黏蛋白(NCAD)多克隆抗体 WB; IHC; ICC; IP.
PAB481Ra01 神经钙黏蛋白(NCAD)多克隆抗体 WB; IHC; ICC; IP.
LAB481Ra71 神经钙黏蛋白(NCAD)多克隆抗体(生物素标记) WB; IHC; ICC.

参考文献

杂志 参考文献
Toxicology Letters Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients. [Pubmed: 23830989]
British journal of haematology Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma. [Pubmed: 23438504]
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Elevated Cerebrospinal Fluid and Plasma N-Cadherin in Alzheimer Disease [Pubmed: 32296844]
Cell Biol Toxicol ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer [33566221]
CELL BIOLOGY AND TOXICOLOGY Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence [33758996]
Pharmacol Res DOC2B is a Negative Regulator of Wnt/β-catenin Signaling Pathway in Cervical Cancer [Pubmed:35500882]
留言咨询